Monte M. Winslow - Publications

Affiliations: 
Stanford University, Palo Alto, CA 
Area:
Genetics

58 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Murray CW, Brady JJ, Tsai MK, Li C, Winters IP, Tang R, Andrejka L, Ma RK, Kunder CA, Chu P, Winslow MM. An Lkb1-Sik axis suppresses lung tumor growth and controls differentiation. Cancer Discovery. PMID 31350327 DOI: 10.1158/2159-8290.CD-18-1237  0.6
2018 Winters IP, Murray CW, Winslow MM. Publisher Correction: Towards quantitative and multiplexed in vivo functional cancer genomics. Nature Reviews. Genetics. PMID 30327497 DOI: 10.1038/s41576-018-0062-6  0.6
2018 Winters IP, Murray CW, Winslow MM. Towards quantitative and multiplexed in vivo functional cancer genomics. Nature Reviews. Genetics. PMID 30267031 DOI: 10.1038/s41576-018-0053-7  0.6
2018 Chiou SH, Dorsch M, Kusch E, Naranjo S, Kozak MM, Koong AC, Winslow MM, Grüner BM. Hmga2 is dispensable for pancreatic cancer development, metastasis, and therapy resistance. Scientific Reports. 8: 14008. PMID 30228296 DOI: 10.1038/s41598-018-32159-x  0.6
2018 Yang D, Denny SK, Greenside PG, Chaikovsky AC, Brady JJ, Ouadah Y, Granja JM, Jahchan NS, Lim JS, Kwok S, Kong CS, Berghoff AS, Schmitt A, Reinhardt HC, Park KS, ... ... Winslow MM, et al. Intertumoral Heterogeneity in SCLC Is Influenced by the Cell Type of Origin. Cancer Discovery. PMID 30228179 DOI: 10.1158/2159-8290.CD-17-0987  0.44
2018 Caswell DR, Chuang CH, Ma RK, Winters IP, Snyder EL, Winslow MM. Tumor Suppressor Activity of Selenbp1, a Direct Nkx2-1 Target, in Lung Adenocarcinoma. Molecular Cancer Research : McR. PMID 30002193 DOI: 10.1158/1541-7786.MCR-18-0392  0.6
2018 Rogers ZN, McFarland CD, Winters IP, Seoane JA, Brady JJ, Yoon S, Curtis C, Petrov DA, Winslow MM. Mapping the in vivo fitness landscape of lung adenocarcinoma tumor suppression in mice. Nature Genetics. PMID 29610476 DOI: 10.1038/s41588-018-0083-2  0.6
2017 Winters IP, Chiou SH, Paulk NK, McFarland CD, Lalgudi PV, Ma RK, Lisowski L, Connolly AJ, Petrov DA, Kay MA, Winslow MM. Multiplexed in vivo homology-directed repair and tumor barcoding enables parallel quantification of Kras variant oncogenicity. Nature Communications. 8: 2053. PMID 29233960 DOI: 10.1038/s41467-017-01519-y  0.6
2017 Chiou SH, Risca VI, Wang GX, Yang D, Grüner BM, Kathiria AS, Ma RK, Vaka D, Chu P, Kozak M, Castellini L, Graves EE, Kim GE, Mourrain P, Koong AC, ... ... Winslow MM, et al. Blimp1 induces transient metastatic heterogeneity in pancreatic cancer. Cancer Discovery. PMID 28790031 DOI: 10.1158/2159-8290.CD-17-0250  0.32
2017 Rogers ZN, McFarland CD, Winters IP, Naranjo S, Chuang CH, Petrov D, Winslow MM. A quantitative and multiplexed approach to uncover the fitness landscape of tumor suppression in vivo. Nature Methods. PMID 28530655 DOI: 10.1038/nmeth.4297  0.6
2017 Chuang CH, Greenside PG, Rogers ZN, Brady JJ, Yang D, Ma RK, Caswell DR, Chiou SH, Winters AF, Grüner BM, Ramaswami G, Spencley AL, Kopecky KE, Sayles LC, Sweet-Cordero EA, ... ... Winslow MM, et al. Molecular definition of a metastatic lung cancer state reveals a targetable CD109-Janus kinase-Stat axis. Nature Medicine. PMID 28191885 DOI: 10.1038/nm.4285  0.6
2016 Grüner BM, Schulze CJ, Yang D, Ogasawara D, Dix MM, Rogers ZN, Chuang CH, McFarland CD, Chiou SH, Brown JM, Cravatt BF, Bogyo M, Winslow MM. An in vivo multiplexed small-molecule screening platform. Nature Methods. PMID 27617390 DOI: 10.1038/nmeth.3992  0.96
2016 Denny SK, Yang D, Chuang CH, Brady JJ, Lim JS, Grüner BM, Chiou SH, Schep AN, Baral J, Hamard C, Antoine M, Wislez M, Kong CS, Connolly AJ, Park KS, ... ... Winslow MM, et al. Nfib Promotes Metastasis through a Widespread Increase in Chromatin Accessibility. Cell. PMID 27374332 DOI: 10.1016/j.cell.2016.05.052  0.96
2016 Weiskopf K, Jahchan NS, Schnorr PJ, Cristea S, Ring AM, Maute RL, Volkmer AK, Volkmer JP, Liu J, Lim JS, Yang D, Seitz G, Nguyen T, Wu D, Jude K, ... ... Winslow MM, et al. CD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancer. The Journal of Clinical Investigation. PMID 27294525 DOI: 10.1172/JCI81603  0.96
2016 Brady JJ, Chuang CH, Greenside PG, Rogers ZN, Murray CW, Caswell DR, Hartmann U, Connolly AJ, Sweet-Cordero EA, Kundaje A, Winslow MM. An Arntl2-Driven Secretome Enables Lung Adenocarcinoma Metastatic Self-Sufficiency. Cancer Cell. PMID 27150038 DOI: 10.1016/j.ccell.2016.03.003  0.96
2015 Robles-Oteiza C, Taylor S, Yates T, Cicchini M, Lauderback B, Cashman CR, Burds AA, Winslow MM, Jacks T, Feldser DM. Recombinase-based conditional and reversible gene regulation via XTR alleles. Nature Communications. 6: 8783. PMID 26537451 DOI: 10.1038/ncomms9783  0.96
2015 Madison BB, Jeganathan AN, Mizuno R, Winslow MM, Castells A, Cuatrecasas M, Rustgi AK. Let-7 Represses Carcinogenesis and a Stem Cell Phenotype in the Intestine via Regulation of Hmga2. Plos Genetics. 11: e1005408. PMID 26244988 DOI: 10.1371/journal.pgen.1005408  0.96
2015 Chiou SH, Winters IP, Wang J, Naranjo S, Dudgeon C, Tamburini FB, Brady JJ, Yang D, Grüner BM, Chuang CH, Caswell DR, Zeng H, Chu P, Kim GE, Carpizo DR, ... ... Winslow MM, et al. Pancreatic cancer modeling using retrograde viral vector delivery and in vivo CRISPR/Cas9-mediated somatic genome editing. Genes & Development. PMID 26178787 DOI: 10.1101/gad.264861.115  0.96
2015 Kumar MS, Armenteros-Monterroso E, East P, Chakravorty P, Matthews N, Winslow MM, Downward J. Retraction: HMGA2 functions as a competing endogenous RNA to promote lung cancer progression. Nature. 523: 370. PMID 26061768 DOI: 10.1038/nature14551  0.96
2015 Ofori LO, Withana NP, Prestwood TR, Verdoes M, Brady JJ, Winslow MM, Sorger J, Bogyo M. Design of Protease Activated Optical Contrast Agents That Exploit a Latent Lysosomotropic Effect for Use in Fluorescence-Guided Surgery. Acs Chemical Biology. 10: 1977-88. PMID 26039341 DOI: 10.1021/acschembio.5b00205  0.96
2015 Valdmanis PN, Roy-Chaudhuri B, Kim HK, Sayles LC, Zheng Y, Chuang CH, Caswell DR, Chu K, Zhang Y, Winslow MM, Sweet-Cordero EA, Kay MA. Upregulation of the microRNA cluster at the Dlk1-Dio3 locus in lung adenocarcinoma. Oncogene. 34: 94-103. PMID 24317514 DOI: 10.1038/onc.2013.523  0.96
2014 Goodwin JM, Svensson RU, Lou HJ, Winslow MM, Turk BE, Shaw RJ. An AMPK-independent signaling pathway downstream of the LKB1 tumor suppressor controls Snail1 and metastatic potential. Molecular Cell. 55: 436-50. PMID 25042806 DOI: 10.1016/j.molcel.2014.06.021  0.96
2014 Sinkevicius KW, Kriegel C, Bellaria KJ, Lee J, Lau AN, Leeman KT, Zhou P, Beede AM, Fillmore CM, Caswell D, Barrios J, Wong KK, Sholl LM, Schlaeger TM, Bronson RT, ... ... Winslow MM, et al. Neurotrophin receptor TrkB promotes lung adenocarcinoma metastasis. Proceedings of the National Academy of Sciences of the United States of America. 111: 10299-304. PMID 24982195 DOI: 10.1073/pnas.1404399111  0.96
2014 Chiou SH, Kim-Kiselak C, Risca VI, Heimann MK, Chuang CH, Burds AA, Greenleaf WJ, Jacks TE, Feldser DM, Winslow MM. A conditional system to specifically link disruption of protein-coding function with reporter expression in mice. Cell Reports. 7: 2078-86. PMID 24931605 DOI: 10.1016/j.celrep.2014.05.031  0.96
2014 Caswell DR, Chuang CH, Yang D, Chiou SH, Cheemalavagu S, Kim-Kiselak C, Connolly A, Winslow MM. Obligate progression precedes lung adenocarcinoma dissemination. Cancer Discovery. 4: 781-9. PMID 24740995 DOI: 10.1158/2159-8290.CD-13-0862  0.96
2014 Kumar MS, Armenteros-Monterroso E, East P, Chakravorty P, Matthews N, Winslow MM, Downward J. HMGA2 functions as a competing endogenous RNA to promote lung cancer progression. Nature. 505: 212-7. PMID 24305048 DOI: 10.1038/nature12785  0.96
2014 Winslow MM, Jacks T. Genetic Mouse Models of Cancer The Molecular Basis of Cancer: Fourth Edition. 145-154.e2. DOI: 10.1016/B978-1-4557-4066-6.00009-3  0.96
2013 Li CM, Chen G, Dayton TL, Kim-Kiselak C, Hoersch S, Whittaker CA, Bronson RT, Beer DG, Winslow MM, Jacks T. Differential Tks5 isoform expression contributes to metastatic invasion of lung adenocarcinoma. Genes & Development. 27: 1557-67. PMID 23873940 DOI: 10.1101/gad.222745.113  0.96
2013 Rice SJ, Lai SC, Wood LW, Helsley KR, Runkle EA, Winslow MM, Mu D. MicroRNA-33a mediates the regulation of high mobility group AT-hook 2 gene (HMGA2) by thyroid transcription factor 1 (TTF-1/NKX2-1). The Journal of Biological Chemistry. 288: 16348-60. PMID 23625920 DOI: 10.1074/jbc.M113.474643  0.96
2013 Byun S, Son S, Amodei D, Cermak N, Shaw J, Kang JH, Hecht VC, Winslow MM, Jacks T, Mallick P, Manalis SR. Characterizing deformability and surface friction of cancer cells. Proceedings of the National Academy of Sciences of the United States of America. 110: 7580-5. PMID 23610435 DOI: 10.1073/pnas.1218806110  0.96
2012 Reticker-Flynn NE, Malta DF, Winslow MM, Lamar JM, Xu MJ, Underhill GH, Hynes RO, Jacks TE, Bhatia SN. A combinatorial extracellular matrix platform identifies cell-extracellular matrix interactions that correlate with metastasis. Nature Communications. 3: 1122. PMID 23047680 DOI: 10.1038/ncomms2128  0.96
2012 Runkle EA, Rice SJ, Qi J, Masser D, Antonetti DA, Winslow MM, Mu D. Occludin is a direct target of thyroid transcription factor-1 (TTF-1/NKX2-1). The Journal of Biological Chemistry. 287: 28790-801. PMID 22761434 DOI: 10.1074/jbc.M112.367987  0.96
2012 Schroeder A, Heller DA, Winslow MM, Dahlman JE, Pratt GW, Langer R, Jacks T, Anderson DG. Treating metastatic cancer with nanotechnology. Nature Reviews. Cancer. 12: 39-50. PMID 22193407 DOI: 10.1038/nrc3180  0.96
2011 Xue W, Meylan E, Oliver TG, Feldser DM, Winslow MM, Bronson R, Jacks T. Response and resistance to NF-κB inhibitors in mouse models of lung adenocarcinoma. Cancer Discovery. 1: 236-47. PMID 21874163 DOI: 10.1158/2159-8290.CD-11-0073  0.96
2011 Dooley AL, Winslow MM, Chiang DY, Banerji S, Stransky N, Dayton TL, Snyder EL, Senna S, Whittaker CA, Bronson RT, Crowley D, Barretina J, Garraway L, Meyerson M, Jacks T. Nuclear factor I/B is an oncogene in small cell lung cancer. Genes & Development. 25: 1470-5. PMID 21764851 DOI: 10.1101/gad.2046711  0.96
2011 Shaw AT, Winslow MM, Magendantz M, Ouyang C, Dowdle J, Subramanian A, Lewis TA, Maglathin RL, Tolliday N, Jacks T. Selective killing of K-ras mutant cancer cells by small molecule inducers of oxidative stress. Proceedings of the National Academy of Sciences of the United States of America. 108: 8773-8. PMID 21555567 DOI: 10.1073/pnas.1105941108  0.96
2011 Winslow MM, Dayton TL, Verhaak RG, Kim-Kiselak C, Snyder EL, Feldser DM, Hubbard DD, DuPage MJ, Whittaker CA, Hoersch S, Yoon S, Crowley D, Bronson RT, Chiang DY, Meyerson M, et al. Suppression of lung adenocarcinoma progression by Nkx2-1. Nature. 473: 101-4. PMID 21471965 DOI: 10.1038/nature09881  0.96
2011 DuPage M, Cheung AF, Mazumdar C, Winslow MM, Bronson R, Schmidt LM, Crowley D, Chen J, Jacks T. Endogenous T cell responses to antigens expressed in lung adenocarcinomas delay malignant tumor progression. Cancer Cell. 19: 72-85. PMID 21251614 DOI: 10.1016/j.ccr.2010.11.011  0.96
2010 Feldser DM, Kostova KK, Winslow MM, Taylor SE, Cashman C, Whittaker CA, Sanchez-Rivera FJ, Resnick R, Bronson R, Hemann MT, Jacks T. Stage-specific sensitivity to p53 restoration during lung cancer progression. Nature. 468: 572-5. PMID 21107428 DOI: 10.1038/nature09535  0.96
2008 Li DH, Winslow MM, Cao TM, Chen AH, Davis CR, Mellins ED, Utz PJ, Crabtree GR, Parnes JR. Modulation of peripheral B cell tolerance by CD72 in a murine model. Arthritis and Rheumatism. 58: 3192-204. PMID 18821699 DOI: 10.1002/art.23812  0.96
2008 Gallo EM, Ho L, Winslow MM, Staton TL, Crabtree GR. Selective role of calcineurin in haematopoiesis and lymphopoiesis. Embo Reports. 9: 1141-8. PMID 18818667 DOI: 10.1038/embor.2008.174  0.96
2008 Ventura A, Young AG, Winslow MM, Lintault L, Meissner A, Erkeland SJ, Newman J, Bronson RT, Crowley D, Stone JR, Jaenisch R, Sharp PA, Jacks T. Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell. 132: 875-86. PMID 18329372 DOI: 10.1016/j.cell.2008.02.019  0.96
2008 Ryoo SR, Jeong HK, Radnaabazar C, Arron JR, Winslow MM, Polleri A. DYRKI A-mediated hyperphosphorylation of tau: A functional link between down syndrome and alzheimer's disease*: NFAT dysregulation by increased dosage of DSCRI and DYRKI A on chromosome 21 Chemtracts. 21: 203-206.  0.96
2007 Gallo EM, Winslow MM, Canté-Barrett K, Radermacher AN, Ho L, McGinnis L, Iritani B, Neilson JR, Crabtree GR. Calcineurin sets the bandwidth for discrimination of signals during thymocyte development. Nature. 450: 731-5. PMID 18046413 DOI: 10.1038/nature06305  0.96
2007 Lessard J, Wu JI, Ranish JA, Wan M, Winslow MM, Staahl BT, Wu H, Aebersold R, Graef IA, Crabtree GR. An essential switch in subunit composition of a chromatin remodeling complex during neural development. Neuron. 55: 201-15. PMID 17640523 DOI: 10.1016/j.neuron.2007.06.019  0.96
2007 Canté-Barrett K, Winslow MM, Crabtree GR. Selective role of NFATc3 in positive selection of thymocytes. Journal of Immunology (Baltimore, Md. : 1950). 179: 103-10. PMID 17579027  0.96
2007 Pan M, Winslow MM, Chen L, Kuo A, Felsher D, Crabtree GR. Enhanced NFATc1 nuclear occupancy causes T cell activation independent of CD28 costimulation. Journal of Immunology (Baltimore, Md. : 1950). 178: 4315-21. PMID 17371988  0.96
2007 Pan M, Winslow MM, Keum JS, Crabtree GR. Stringent control of NFATc1 nuclear occupancy is critical for maintaining balanced immune response Gene Therapy and Molecular Biology. 11: 171-176.  0.96
2006 Heit JJ, Apelqvist AA, Gu X, Winslow MM, Neilson JR, Crabtree GR, Kim SK. Calcineurin/NFAT signalling regulates pancreatic beta-cell growth and function. Nature. 443: 345-9. PMID 16988714 DOI: 10.1038/nature05097  0.96
2006 Winslow MM, Pan M, Starbuck M, Gallo EM, Deng L, Karsenty G, Crabtree GR. Calcineurin/NFAT signaling in osteoblasts regulates bone mass. Developmental Cell. 10: 771-82. PMID 16740479 DOI: 10.1016/j.devcel.2006.04.006  0.96
2006 Staton TL, Habtezion A, Winslow MM, Sato T, Love PE, Butcher EC. CD8+ recent thymic emigrants home to and efficiently repopulate the small intestine epithelium. Nature Immunology. 7: 482-8. PMID 16582913 DOI: 10.1038/ni1319  0.96
2006 Arron JR, Winslow MM, Polleri A, Chang CP, Wu H, Gao X, Neilson JR, Chen L, Heit JJ, Kim SK, Yamasaki N, Miyakawa T, Francke U, Graef IA, Crabtree GR. NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21. Nature. 441: 595-600. PMID 16554754 DOI: 10.1038/nature04678  0.96
2006 Winslow MM, Gallo EM, Neilson JR, Crabtree GR. The calcineurin phosphatase complex modulates immunogenic B cell responses. Immunity. 24: 141-52. PMID 16473827 DOI: 10.1016/j.immuni.2005.12.013  0.96
2006 Canté-Barrett K, Gallo EM, Winslow MM, Crabtree GR. Thymocyte negative selection is mediated by protein kinase C- and Ca2+-dependent transcriptional induction of bim [corrected]. Journal of Immunology (Baltimore, Md. : 1950). 176: 2299-306. PMID 16455986  0.96
2005 Winslow MM, Crabtree GR. Immunology. Decoding calcium signaling. Science (New York, N.Y.). 307: 56-7. PMID 15637261 DOI: 10.1126/science.1108163  0.96
2004 Neilson JR, Winslow MM, Hur EM, Crabtree GR. Calcineurin B1 is essential for positive but not negative selection during thymocyte development. Immunity. 20: 255-66. PMID 15030770 DOI: 10.1016/S1074-7613(04)00052-4  0.96
2003 Winslow MM, Neilson JR, Crabtree GR. Calcium signalling in lymphocytes. Current Opinion in Immunology. 15: 299-307. PMID 12787755 DOI: 10.1016/S0952-7915(03)00050-5  0.96
2002 Valdez Y, Mah W, Winslow MM, Xu L, Ling P, Townsend SE. Major histocompatibility complex class II presentation of cell-associated antigen is mediated by CD8alpha+ dendritic cells in vivo. The Journal of Experimental Medicine. 195: 683-94. PMID 11901195 DOI: 10.1084/jem.20010898  0.96
Show low-probability matches.